370 related articles for article (PubMed ID: 23242368)
1. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma.
Jiang DK; Sun J; Cao G; Liu Y; Lin D; Gao YZ; Ren WH; Long XD; Zhang H; Ma XP; Wang Z; Jiang W; Chen TY; Gao Y; Sun LD; Long JR; Huang HX; Wang D; Yu H; Zhang P; Tang LS; Peng B; Cai H; Liu TT; Zhou P; Liu F; Lin X; Tao S; Wan B; Sai-Yin HX; Qin LX; Yin J; Liu L; Wu C; Pei Y; Zhou YF; Zhai Y; Lu PX; Tan A; Zuo XB; Fan J; Chang J; Gu X; Wang NJ; Li Y; Liu YK; Zhai K; Zhang H; Hu Z; Liu J; Yi Q; Xiang Y; Shi R; Ding Q; Zheng W; Shu XO; Mo Z; Shugart YY; Zhang XJ; Zhou G; Shen H; Zheng SL; Xu J; Yu L
Nat Genet; 2013 Jan; 45(1):72-5. PubMed ID: 23242368
[TBL] [Abstract][Full Text] [Related]
2. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci of STAT4 and HLA-DQ in a Korean population.
Kim LH; Cheong HS; Namgoong S; Kim JO; Kim JH; Park BL; Cho SW; Park NH; Cheong JY; Koh I; Shin HD; Kim YJ
Infect Genet Evol; 2015 Jul; 33():72-6. PubMed ID: 25913043
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis.
Jiang DK; Ma XP; Wu X; Peng L; Yin J; Dan Y; Huang HX; Ding DL; Zhang LY; Shi Z; Zhang P; Yu H; Sun J; Lilly Zheng S; Deng G; Xu J; Liu Y; Guo J; Cao G; Yu L
Sci Rep; 2015 Nov; 5():16278. PubMed ID: 26538132
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA-DP/DQ and STAT4 polymorphisms with HBV infection outcomes and a mini meta-analysis.
Liao Y; Cai B; Li Y; Chen J; Tao C; Huang H; Wang L
PLoS One; 2014; 9(11):e111677. PubMed ID: 25365208
[TBL] [Abstract][Full Text] [Related]
5. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
6. The effects of the interactions of STAT4 rs7574865 with HBV mutations on the risk of hepatocellular carcinoma.
Yang C; Chen H; Zhou B; Yin J; Cao G; Hou J; Jiang D
Mol Carcinog; 2022 Oct; 61(10):933-940. PubMed ID: 35880842
[TBL] [Abstract][Full Text] [Related]
7. Association of
Shi H; He H; Ojha SC; Sun C; Fu J; Yan M; Deng C; Sheng Y
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31160486
[No Abstract] [Full Text] [Related]
8. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
[TBL] [Abstract][Full Text] [Related]
9. A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma.
Clark A; Gerlach F; Tong Hv; Hoan NX; Song le H; Toan NL; Bock CT; Kremsner PG; Velavan TP
Infect Genet Evol; 2013 Aug; 18():257-61. PubMed ID: 23748017
[TBL] [Abstract][Full Text] [Related]
10. Association of HLA-DP/DQ, STAT4 and IL-28B variants with HBV viral clearance in Tibetans and Uygurs in China.
Liao Y; Cai B; Li Y; Chen J; Ying B; Tao C; Zhao M; Ba Z; Zhang Z; Wang L
Liver Int; 2015 Mar; 35(3):886-96. PubMed ID: 25041342
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study.
Wen J; Song C; Jiang D; Jin T; Dai J; Zhu L; An J; Liu Y; Ma S; Qin N; Liang C; Chen J; Jiang Y; Yang L; Liu J; Liu L; Geng T; Chen C; Jiang J; Chen J; Zhu F; Zhu Y; Yu L; Shen H; Zhai X; Xu J; Hu Z
Sci Rep; 2015 Nov; 5():16489. PubMed ID: 26568165
[TBL] [Abstract][Full Text] [Related]
12. Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population.
Chen K; Shi W; Xin Z; Wang H; Zhu X; Wu X; Li Z; Li H; Liu Y
PLoS One; 2013; 8(10):e77315. PubMed ID: 24204805
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome-wide association study for persistent hepatitis B virus infection and related hepatocellular carcinoma.
Han J; Chen C; Wang C; Qin N; Huang M; Ma Z; Zhu M; Dai J; Jiang Y; Ma H; Jin G; Shen H; Hu Z
Liver Int; 2020 Sep; 40(9):2117-2127. PubMed ID: 32574393
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism of HLA-DQ confers susceptibility to hepatitis B virus-related hepatocellular carcinoma: a case-control study in Han population in China.
Gao X; Liu W; Zhang X; Tang L; Wang L; Yan L; Yang H; Li T; Yang L; Ma N; Liu D
Tumour Biol; 2016 Sep; 37(9):12103-12111. PubMed ID: 27209411
[TBL] [Abstract][Full Text] [Related]
15. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers.
Li S; Qian J; Yang Y; Zhao W; Dai J; Bei JX; Foo JN; McLaren PJ; Li Z; Yang J; Shen F; Liu L; Yang J; Li S; Pan S; Wang Y; Li W; Zhai X; Zhou B; Shi L; Chen X; Chu M; Yan Y; Wang J; Cheng S; Shen J; Jia W; Liu J; Yang J; Wen Z; Li A; Zhang Y; Zhang G; Luo X; Qin H; Chen M; Wang H; Jin L; Lin D; Shen H; He L; de Bakker PI; Wang H; Zeng YX; Wu M; Hu Z; Shi Y; Liu J; Zhou W
PLoS Genet; 2012; 8(7):e1002791. PubMed ID: 22807686
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma.
Sawai H; Nishida N; Khor SS; Honda M; Sugiyama M; Baba N; Yamada K; Sawada N; Tsugane S; Koike K; Kondo Y; Yatsuhashi H; Nagaoka S; Taketomi A; Fukai M; Kurosaki M; Izumi N; Kang JH; Murata K; Hino K; Nishina S; Matsumoto A; Tanaka E; Sakamoto N; Ogawa K; Yamamoto K; Tamori A; Yokosuka O; Kanda T; Sakaida I; Itoh Y; Eguchi Y; Oeda S; Mochida S; Yuen MF; Seto WK; Poovorawan Y; Posuwan N; Mizokami M; Tokunaga K
Sci Rep; 2018 May; 8(1):7958. PubMed ID: 29784950
[TBL] [Abstract][Full Text] [Related]
17. Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
Chanthra N; Payungporn S; Chuaypen N; Piratanantatavorn K; Pinjaroen N; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(18):8405-10. PubMed ID: 26745093
[TBL] [Abstract][Full Text] [Related]
18. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.
Jiang D; Deng J; Dong C; Ma X; Xiao Q; Zhou B; Yang C; Wei L; Conran C; Zheng SL; Ng IO; Yu L; Xu J; Sham PC; Qi X; Hou J; Ji Y; Cao G; Li M
BMC Cancer; 2020 May; 20(1):403. PubMed ID: 32393195
[TBL] [Abstract][Full Text] [Related]
19. The STAT4 and not the IFNL3 variant is associated with hepatitis B virus clearance in a population from the Khyber Pakhtunkhwa region of Pakistan.
Jalil I; Arshad M; Khan S; Dasti JI
Arab J Gastroenterol; 2020 Jun; 21(2):91-94. PubMed ID: 32439233
[TBL] [Abstract][Full Text] [Related]
20. STAT4 gene polymorphism and risk of chronic hepatitis B-induced hepatocellular carcinoma.
Zhao X; Jiang K; Liang B; Huang X
Cell Biochem Biophys; 2015 Jan; 71(1):353-7. PubMed ID: 25178516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
